Invest now
Fredun Pharmaceuticals share price
High risk
You have to be logged in to add this to Watchlist.- ₹1,350.40(-0.19%)October 5, 2026 15:25:32 PM IST
- NSE
- BSE
- Vol : 77.25 K (NSE + BSE)Last 20 day avg : 84.41 K
Fredun Pharmaceuticals is trading -0.19% lower at Rs 1,350.40 as compared to its last closing price. Fredun Pharmaceuticals has been trading in the price range of 1,386.05 & 1,324.10. The company posted a net profit of 13.13 Crores in its last quarter.Listed peers of Fredun Pharmaceuticals include Sun Pharmaceutical Industries (-1.55%), Divi's Laboratories (-0.88%), Torrent Pharmaceuticals (-0.14%).The Mutual Fund holding in Fredun Pharmaceuticals was at -% in . The MF holding has - from the last quarter. The FII holding in Fredun Pharmaceuticals was at 1.06% in 16 Jul 2026. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 05 Oct 2026, 09:19 PM IST
- Debt To EquityHigher than industry0.87The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.02Annual dividends as a percentage of the stock price.
- P/BHigher than historical values8.06The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values50.55Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates Fair Valuation1.28The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- Beta-Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Fredun Pharmaceuticals News
Fredun Pharmaceuticals Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,782.00 | -1.55 | 4,27,551.42 | 38.40 | 5.55 | 0.83 | 0.47 |
| Divi's Laboratories | 9,212.85 | -0.88 | 2,44,572.22 | 73.32 | 11.48 | 0.41 | 0.03 |
| Torrent Pharmaceuticals | 4,755.15 | -0.14 | 1,80,864.15 | 72.73 | 19.22 | 0.80 | 141.16 |
| Cipla | 1,334.00 | -0.95 | 1,07,768.31 | 27.57 | 3.33 | 0.92 | 1.11 |
| Zydus Lifesciences | 1,138.50 | -0.59 | 1,13,565.81 | 21.19 | 4.24 | 0.09 | 14.22 |
Fredun Pharmaceuticals Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-08-05 | Quarterly Results |
| 2026-05-25 | Audited Results, Dividend & Bonus issue |
| 2026-02-09 | Quarterly Results |
| 2025-11-08 | Quarterly Results |
| 2025-09-25 | Preferential Issue of shares & Others |
About the company Fredun Pharmaceuticals
- IndustryBiotechnology & Drugs
- ISININE194R01017
- BSE Code539730
- NSE Code
Fredun Pharmaceuticals Ltd. is an India-based pharmaceuticals formulation manufacturing company. The Company is engaged in manufacturing dietary/herbal supplements, nutraceuticals, and other healthcare products, along with animal healthcare products. Its segment includes Fredun Generics, Pet Care, Nutraceuticals, Cosmeceuticals and Mobility. Its Generics Division, marketed under the Fredun Gx brand. The Pet Healthcare segment operates under the Freossi brand. The Nutraceutical Division under Fredun Nutrition brand. Its Cosmeceuticals Division, operating under the Bird N Beauty (BNB) and Beautyfred brands, is focused on skincare and personal care products. Its Mobility Division, operating under Chuu Balm, BraceOn, NebOn, and DigiOn, caters to the ortho rehabilitation aids and pain management market. It offers a range of products, including antihypertensive, antidiabetic, antiretroviral drugs (ARVs) and narcotics. It also provides comprehensive pet care technology platforms.
Fredun Pharmaceuticals Share Price FAQs
Fredun Pharmaceuticals is trading at 1350.40 as on Mon Oct 05 2026 09:55:32. This is -0.19% lower as compared to its previous closing price of 1353.00.
The market capitalization of Fredun Pharmaceuticals is 2212.86 Cr as on Mon Oct 05 2026 09:55:32.
The 52 wk high for Fredun Pharmaceuticals is 1600.00 whereas the 52 wk low is 427.00
Fredun Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E:
- Sector P/E: 33.86
- Dividend Yield: 0.02%
- D/E ratio: -
Fredun Pharmaceuticals reported a net profit of 32.62 Cr in 2026.
Quick Links
EQUITY QUICK LINKS
Fredun Pharmaceuticals QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.